SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-22-069330
Filing Date
2022-06-08
Accepted
2022-06-08 16:24:10
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2217857d1_10ka.htm   iXBRL 10-K/A 43980
2 EXHIBIT 31.1 tm2217857d1_ex31-1.htm EX-31.1 13136
3 EXHIBIT 31.2 tm2217857d1_ex31-2.htm EX-31.2 12750
4 EXHIBIT 31.3 tm2217857d1_ex31-3.htm EX-31.3 13108
5 EXHIBIT 31.4 tm2217857d1_ex31-4.htm EX-31.4 13001
  Complete submission text file 0001104659-22-069330.txt   368262

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gls-20211231.xsd EX-101.SCH 3774
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gls-20211231_def.xml EX-101.DEF 28316
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gls-20211231_lab.xml EX-101.LAB 38932
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gls-20211231_pre.xml EX-101.PRE 26926
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2217857d1_10ka_htm.xml XML 7596
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39362 | Film No.: 221003799
SIC: 2834 Pharmaceutical Preparations